Cellebrite schedules November 12 results. Analysts target Cellebrite stock at USD 16.70

Published on 10/20/2026 at 20:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cellebrite's market value was USD 2.9 billion on October 20, 2026. Cellebrite stock costs EUR 10.16 on October 20, 2026 at 8:07 p.m. CEST.

November reporting date

Cellebrite announced its third-quarter results date of November 12, 2026, on October 20, 2026.
MarketBeat cited a USD 16.70 average target from six research firms on October 20, 2026.
Cellebrite stock costs EUR 10.16 at Lang & Schwarz on October 20, 2026 at 8:07 p.m. CEST.

CLBT, IL0011794802, Illustration mit AI erstellt.

Cellebrite DI Ltd. (ISIN IL0011794802) will report its third-quarter 2026 financial results before the U.S. market opens on November 12, 2026, the company announced on October 20, 2026, in a release carried by Cellebrite. MarketBeat reported on October 20, 2026, that six research firms carried a consensus rating of Moderate Buy and an average 12-month target of USD 16.70. Cellebrite stock was trading at EUR 10.16 at Lang & Schwarz on October 20, 2026 at 8:07 p.m. CEST.

Analysts set a USD 16.70 target

The consensus target gives the November reporting date a measurable valuation reference. MarketBeat said five firms rated Cellebrite a Buy and one assigned a Sell rating on October 20, 2026, while the average target stood at USD 16.70.

Market value and yearly range

Cellebrite's Nasdaq quote was USD 11.41 on October 20, 2026 at 2:11 p.m. EDT, while its 52-week range stood at USD 9.58 to USD 19.98. The distance between the USD 11.41 quote and the yearly high was USD 8.57, placing the quote 42.84 percent below that high.

The company's market capitalization was USD 2.9 billion on October 20, 2026. The financial calendar therefore gives investors a specific near-term date for the next operating update, while the consensus target remains materially above the Nasdaq quote.

November 12 brings the next test

The November 12 release will cover the third quarter of 2026 and include a conference call at 8:30 a.m. ET, according to the October 20, 2026 company release. Management is scheduled to discuss the results and the 2026 outlook during the same session.

Cellebrite stock in euro trading

The euro quotation stood at EUR 10.16 at Lang & Schwarz on October 20, 2026 at 8:07 p.m. CEST. The next scheduled company event is the third-quarter report on November 12, 2026.

The further course of trading is shown by the continuously updated real-time quote of Cellebrite stock.